Comment in response to “temozolomide in glioblastoma therapy: role of apoptosis, senescence and autophagy etc. by B. Kaina”

Thumbnail

peer-reviewed

Erstveröffentlichung
2020-04-20
Authors
Westhoff, Mike-Andrew
Baisch, Tim
Herbener, Verena J.
Karpel-Massler, Georg
Debatin, Klaus-Michael
et al.
Wissenschaftlicher Artikel


Published in
Biomedicines ; 8 (2020), 4. - Art.-Nr. 93. - eISSN 2227-9059
Link to original publication
https://dx.doi.org/10.3390/biomedicines8040093
Institutions
UKU. Klinik für Kinder- und Jugendmedizin
UKU. Klinik für Neurochirurgie
Document version
published version (publisher's PDF)
Subject headings
[GND]: Glioblastom | Strahlentherapie
[MeSH]: Glioblastoma; Radiotherapy | Apoptosis | Temozolomide
[Free subject headings]: Temozolomide | Apoptosis Inducer | Fractionated radiation therapy
[DDC subject group]: DDC 610 / Medicine & health
License
CC BY 4.0 International
https://creativecommons.org/licenses/by/4.0/
Metadata
Show full item record

DOI & citation

Please use this identifier to cite or link to this item: http://dx.doi.org/10.18725/OPARU-42296

Westhoff, Mike-Andrew et al. (2022): Comment in response to “temozolomide in glioblastoma therapy: role of apoptosis, senescence and autophagy etc. by B. Kaina”. Open Access Repositorium der Universität Ulm und Technischen Hochschule Ulm. http://dx.doi.org/10.18725/OPARU-42296
Citation formatter >